BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

179 related articles for article (PubMed ID: 24317794)

  • 21. Genetic susceptibility to pre diabetes mellitus and related association with obesity and physical fitness components in Mexican-Mestizos.
    Costa-Urrutia P; Abud C; Franco-Trecu V; Colistro V; Rodríguez-Arellano ME; Granados J; Seelaender M
    Prim Care Diabetes; 2018 Oct; 12(5):416-424. PubMed ID: 30041843
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Assessment of
    Chen Z; Wang Y; Wang J; Kang M; Tang W; Chen S
    DNA Cell Biol; 2020 Sep; 39(9):1521-1531. PubMed ID: 32721231
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Peroxisome proliferator-activated receptor-gamma coactivator-1 and insulin resistance: acute effect of fatty acids.
    Hoeks J; Hesselink MK; Russell AP; Mensink M; Saris WH; Mensink RP; Schrauwen P
    Diabetologia; 2006 Oct; 49(10):2419-26. PubMed ID: 16896940
    [TBL] [Abstract][Full Text] [Related]  

  • 24. PPARGC1A coding variation may initiate impaired NEFA clearance during glucose challenge.
    Franks PW; Ekelund U; Brage S; Luan J; Schafer AJ; O'Rahilly S; Barroso I; Wareham NJ
    Diabetologia; 2007 Mar; 50(3):569-73. PubMed ID: 17216277
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Does DNA methylation of PPARGC1A influence insulin action in first degree relatives of patients with type 2 diabetes?
    Gillberg L; Jacobsen SC; Ribel-Madsen R; Gjesing AP; Boesgaard TW; Ling C; Pedersen O; Hansen T; Vaag A
    PLoS One; 2013; 8(3):e58384. PubMed ID: 23505498
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Aberrant hepatic TRIB3 gene expression in insulin-resistant obese humans.
    Oberkofler H; Pfeifenberger A; Soyal S; Felder T; Hahne P; Miller K; Krempler F; Patsch W
    Diabetologia; 2010 Sep; 53(9):1971-5. PubMed ID: 20461355
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The 482Ser of PPARGC1A and 12Pro of PPARG2 Alleles Are Associated with Reduction of Metabolic Risk Factors Even Obesity in a Mexican-Mestizo Population.
    Vázquez-Del Mercado M; Guzmán-Ornelas MO; Corona Meraz FI; Ríos-Ibarra CP; Reyes-Serratos EA; Castro-Albarran J; Ruíz-Quezada SL; Navarro-Hernández RE
    Biomed Res Int; 2015; 2015():285491. PubMed ID: 26185753
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Common variants in 40 genes assessed for diabetes incidence and response to metformin and lifestyle intervention in the diabetes prevention program.
    Jablonski KA; McAteer JB; de Bakker PI; Franks PW; Pollin TI; Hanson RL; Saxena R; Fowler S; Shuldiner AR; Knowler WC; Altshuler D; Florez JC;
    Diabetes; 2010 Oct; 59(10):2672-81. PubMed ID: 20682687
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Haplotype-based interaction of the PPARGC1A and UCP1 genes is associated with impaired fasting glucose or type 2 diabetes mellitus.
    Pei X; Liu L; Cai J; Wei W; Shen Y; Wang Y; Chen Y; Sun P; Imam MU; Ping Z; Fu X
    Medicine (Baltimore); 2017 Jun; 96(23):e6941. PubMed ID: 28591028
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Increased risk of obesity associated with the variant allele of the PPARGC1A Gly482Ser polymorphism in physically inactive elderly men.
    Ridderstråle M; Johansson LE; Rastam L; Lindblad U
    Diabetologia; 2006 Mar; 49(3):496-500. PubMed ID: 16474966
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The bovine PPARGC1A gene: molecular characterization and association of an SNP with variation of milk fat synthesis.
    Weikard R; Kühn C; Goldammer T; Freyer G; Schwerin M
    Physiol Genomics; 2005 Mar; 21(1):1-13. PubMed ID: 15781588
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Effects of genetic variants previously associated with fasting glucose and insulin in the Diabetes Prevention Program.
    Florez JC; Jablonski KA; McAteer JB; Franks PW; Mason CC; Mather K; Horton E; Goldberg R; Dabelea D; Kahn SE; Arakaki RF; Shuldiner AR; Knowler WC;
    PLoS One; 2012; 7(9):e44424. PubMed ID: 22984506
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The Gly482Ser missense mutation of the peroxisome proliferator-activated receptor gamma coactivator-1 alpha (PGC-1 alpha) gene associates with reduced insulin sensitivity in normal and glucose-intolerant obese subjects.
    Fanelli M; Filippi E; Sentinelli F; Romeo S; Fallarino M; Buzzetti R; Leonetti F; Baroni MG
    Dis Markers; 2005; 21(4):175-80. PubMed ID: 16403952
    [TBL] [Abstract][Full Text] [Related]  

  • 34. PPARGC1A variation associated with DNA damage, diabetes, and cardiovascular diseases: the Boston Puerto Rican Health Study.
    Lai CQ; Tucker KL; Parnell LD; Adiconis X; García-Bailo B; Griffith J; Meydani M; Ordovás JM
    Diabetes; 2008 Apr; 57(4):809-16. PubMed ID: 18162502
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Association between the PPARGC1A Gly482Ser polymorphism and muscle fitness in Chinese schoolchildren.
    Wei Q
    PLoS One; 2023; 18(4):e0284827. PubMed ID: 37104269
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Genes involved in mitochondrial biogenesis/function are induced in response to bilio-pancreatic diversion in morbidly obese individuals with normal glucose tolerance but not in type 2 diabetic patients.
    Hernández-Alvarez MI; Chiellini C; Manco M; Naon D; Liesa M; Palacín M; Mingrone G; Zorzano A
    Diabetologia; 2009 Aug; 52(8):1618-27. PubMed ID: 19504086
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Genetic variation in fatty acid-binding protein-4 and peroxisome proliferator-activated receptor gamma interactively influence insulin sensitivity and body composition in males.
    Damcott CM; Moffett SP; Feingold E; Barmada MM; Marshall JA; Hamman RF; Ferrell RE
    Metabolism; 2004 Mar; 53(3):303-9. PubMed ID: 15015141
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A Gly482Ser missense mutation in the peroxisome proliferator-activated receptor gamma coactivator-1 is associated with altered lipid oxidation and early insulin secretion in Pima Indians.
    Muller YL; Bogardus C; Pedersen O; Baier L
    Diabetes; 2003 Mar; 52(3):895-8. PubMed ID: 12606537
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The Role of Peroxisome Proliferator-Activated Receptors and Their Transcriptional Coactivators Gene Variations in Human Trainability: A Systematic Review.
    Petr M; Stastny P; Zajac A; Tufano JJ; Maciejewska-Skrendo A
    Int J Mol Sci; 2018 May; 19(5):. PubMed ID: 29762540
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Association between PPARγ, PPARGC1A, and PPARGC1B genetic variants and susceptibility of gastric cancer in an Eastern Chinese population.
    Chen B; Wang Y; Tang W; Chen Y; Liu C; Kang M; Xie J
    BMC Med Genomics; 2022 Dec; 15(1):274. PubMed ID: 36587194
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.